Sep 30, 2016

United Therapeutics Q3 2016 Earnings Report

Total Revenue
$408M
Previous year: $386M
+5.7%
EPS
$4.36
Previous year: $3.55
+22.8%
Gross Profit
$385M
Previous year: $379M
+1.4%
Cash and Equivalents
$953M
Previous year: $765M
+24.5%
Free Cash Flow
$220M
Total Assets
$2.27B
Previous year: $2.16B
+5.1%

United Therapeutics

United Therapeutics